BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Employee Elected Board Member Change in Zealand Pharma – Dec. 1, 2017

  The company said Rasmus Just, Director of Business Development and employee-elected Board Member, leaves the company effective from 1 December 2017.

  December 1, 2017

   · 

  1 min read
• Drug Development

  Photocure ASA: Blue Light Flexible Cystoscopy With Cysview Phase III Study: New Data Presented at Society of Urological Oncology

  Four separate posters were presented, including one using patient reported outcomes data from this study demonstrated the positive impact of Cysview on patient Quality of Life.

  December 1, 2017

   · 

  4 min read
• Business

  Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America

  Mr. Beller will join the Nexstim Management Team and report to CEO Martin Jamieson.

  December 1, 2017

   · 

  3 min read
• Drug Development

  VM BioPharma Announces Initiation of Hepatocyte Growth Factor to Improve Functioning in PAD, HI-PAD, Study of VM202 in Peripheral Artery Disease

  VM BioPharma today announced the launch of the HI-PAD study, a trial to investigate the effect of VM202, a DNA plasmid encoding HGF, on mobility and calf perfusion in older adults with PAD.

  December 1, 2017

   · 

  6 min read
• 

  Business

  Basilea Snags Extended $226M+ Antifungal Deal With Pfizer

  Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales.

  December 1, 2017

   · 

  5 min read
• Veloxis Increases Share Capital in Connection With Exercise of Warrants - Dec. 1, 2017

  As a result of the employee’s investment in the Company proceeds to Veloxis Pharmaceuticals A/S from the capital increase amounts to DKK 520,164.

  December 1, 2017

   · 

  1 min read
• Pharm Country

  Tauriga Sciences Fully Repays $45,000 8% Face Value Convertible Debenture Issued to GS Capital Partners, LLC for One Time Cash Payment of $61,664.79

  This convertible debenture, which was issued by the Company on May 30, 2017, has been fully repaid for a one-time cash payment of $61,664.79 USD.

  December 1, 2017

   · 

  3 min read
• Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch

  The grant, together with contributions from the city and province of Groningen, totals EUR 1.2 million.

  December 1, 2017

   · 

  1 min read
• Skyline Medical Announces the Completion of Private Placement for Gross Proceeds of $1,300,000

  The closing of the private placement occurred on November 28, 2017.

  December 1, 2017

   · 

  5 min read
• Business

  Lonza, Akouos and MEE Announce Strategic Gene Therapy License Agreements on Hearing and Balance Disorders

  The agreement with Akouos is designed to accelerate AAV gene therapy for hearing and balance disorder.

  December 1, 2017

   · 

  3 min read